. Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairment. Alzheimers Dement (Amst). 2024;16(3):e12621. Epub 2024 Jul 23 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.